Elevated androgenic hormones in women (hyperandrogenism)

FAI estimates the amount of active testosterone in the blood relative to binding proteins.

The primary male sex hormone responsible for sexual development, sperm production, muscle mass maintenance, bone density, and overall energy levels. Low levels can cause fatigue, reduced libido, erectile dysfunction, decreased muscle mass, and mood changes. Age-related decline is normal, but significant deficiency may warrant supplementation.

A glycoprotein that regulates hormone bioavailability by binding to sex hormones in circulation. SHBG levels influence the amount of active hormones available to tissues and can reflect metabolic and endocrine health.

The unbound, biologically active fraction of total testosterone that can interact with cellular receptors. This measurement provides insight into androgenic activity affecting metabolism, body composition, and various physiological functions. In this panel it is a calculated value: rather than being measured directly, it is derived from total testosterone, SHBG and albumin using the Vermeulen equation (the laboratory reference method is equilibrium dialysis). Because the calculation corrects for SHBG, free testosterone is the guideline-preferred measure of androgen status when SHBG is abnormal or total testosterone sits near the lower limit of normal, and it is more sensitive than total testosterone for detecting male hypogonadism and female androgen excess such as PCOS.

A hormone produced primarily by the adrenal glands that serves as a precursor for testosterone and estrogen. Levels naturally peak in early adulthood and decline with age. Some research suggests maintaining healthy DHEA-S levels may support energy, immune function, and stress resilience, though evidence for supplementation remains mixed.